المؤلفون: Seledtsova GV; Institute of Fundamental and Clinical Immunology; Novosibirsk, Russia., Shishkov AA; Institute of Fundamental and Clinical Immunology; Novosibirsk, Russia., Kaschenko EA; Institute of Fundamental and Clinical Immunology; Novosibirsk, Russia., Goncharov AG; lmmanuel Kant Baltic Federal University, 3 Botkin str., 236016 Kaliningrad, Russia., Gazatova ND; lmmanuel Kant Baltic Federal University, 3 Botkin str., 236016 Kaliningrad, Russia., Seledtsov VI; lmmanuel Kant Baltic Federal University, 3 Botkin str., 236016 Kaliningrad, Russia.

المصدر: European journal of dermatology : EJD [Eur J Dermatol] 2016 Apr 01; Vol. 26 (2), pp. 138-43.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Libbey Eurotext Country of Publication: France NLM ID: 9206420 Publication Model: Print Cited Medium: Internet ISSN: 1952-4013 (Electronic) Linking ISSN: 11671122 NLM ISO Abbreviation: Eur J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Active*, Antigens, Heterophile/*immunology , Cancer Vaccines/*immunology , Cancer Vaccines/*therapeutic use , Melanoma/*therapy , Melanoma, Experimental/*immunology , Skin Neoplasms/*therapy, Animals ; Cancer Vaccines/adverse effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cytokines/blood ; Female ; Humans ; Immunoglobulins/blood ; Lymphocyte Count ; Male ; Melanoma/pathology ; Melanoma/surgery ; Mice ; Middle Aged ; Neoplasm Staging ; Skin Neoplasms/secondary ; Skin Neoplasms/surgery ; Survival Rate ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology